{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Quetiapine+Fumarate&page=2", "query": { "intervention": "Quetiapine Fumarate", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 158, "total_pages": 16, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Quetiapine+Fumarate&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Quetiapine+Fumarate&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-04T00:11:28.290Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01157351", "title": "15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "paliperidone", "type": "DRUG" }, { "name": "risperidone", "type": "DRUG" }, { "name": "haloperidole", "type": "DRUG" }, { "name": "perphenazine", "type": "DRUG" }, { "name": "aripiprazole", "type": "DRUG" }, { "name": "quetiapine", "type": "DRUG" }, { "name": "paliperidone palmitate", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 450, "start_date": "2010-05", "completion_date": "2013-12", "has_results": true, "last_update_posted_date": "2015-04-24", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 55, "location_summary": "Bullhead City, Arizona • Tuscon, Arizona • Little Rock, Arkansas + 52 more", "locations": [ { "city": "Bullhead City", "state": "Arizona" }, { "city": "Tuscon", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Escondido", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01157351" }, { "nct_id": "NCT00081380", "title": "Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Seroquel®, quetiapine fumarate (atypical antipsychotic)", "type": "DRUG" }, { "name": "lithium (mood stabilizer)", "type": "DRUG" }, { "name": "divalproex (mood stabilizer)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 710, "start_date": "2004-03", "completion_date": "2006-09", "has_results": false, "last_update_posted_date": "2008-12-22", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Little Rock, Arkansas + 78 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00081380" }, { "nct_id": "NCT00223249", "title": "Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder", "Alcohol Abuse/Dependence" ], "interventions": [ { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 115, "start_date": "2002-11", "completion_date": "2004-08", "has_results": false, "last_update_posted_date": "2016-04-04", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00223249" }, { "nct_id": "NCT00206128", "title": "Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Seroquel SR", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 454, "start_date": "2004-11", "completion_date": "2006-02", "has_results": false, "last_update_posted_date": "2013-01-04", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Anaheim, California • Cerritos, California + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "National City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00206128" }, { "nct_id": "NCT00375557", "title": "Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementia Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Alzheimer's Disease", "Dementia", "Behavioral Symptoms" ], "interventions": [ { "name": "Divalproex ER", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 0, "start_date": "2006-10", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2015-05-27", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00375557" }, { "nct_id": "NCT00277667", "title": "Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lindner Center of HOPE", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2004-02", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2009-03-13", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00277667" }, { "nct_id": "NCT02901587", "title": "Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder" ], "interventions": [ { "name": "Lu AF35700 (10 mg/day)", "type": "DRUG" }, { "name": "Lu AF35700 (30 mg/day)", "type": "DRUG" }, { "name": "Quetiapine (Seroquel XR® 800 mg/day)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "21 Years to 60 Years" }, "enrollment_count": 119, "start_date": "2016-09", "completion_date": "2018-04-18", "has_results": false, "last_update_posted_date": "2019-09-12", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 1, "location_summary": "Long Beach, California", "locations": [ { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02901587" }, { "nct_id": "NCT00550394", "title": "Efficacy and Tolerability of Topiramate in Treatment of Bipolar Mania and Alcohol Use in Adolescents and Young Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Bipolar Disorder", "Alcohol Abuse" ], "interventions": [ { "name": "quetiapine and placebo", "type": "DRUG" }, { "name": "Quetiapine and Topiramate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "12 Years to 25 Years" }, "enrollment_count": 56, "start_date": "2008-04", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2017-05-23", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00550394" }, { "nct_id": "NCT00315900", "title": "Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Agitation", "Dementia" ], "interventions": [ { "name": "Depakote ER", "type": "DRUG" }, { "name": "Seroquel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tuscaloosa Research & Education Advancement Corporation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 20, "start_date": "2006-05-01", "completion_date": "2008-02-28", "has_results": false, "last_update_posted_date": "2017-04-27", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 1, "location_summary": "Tuscaloosa, Alabama", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00315900" }, { "nct_id": "NCT00232336", "title": "Quetiapine for Cocaine Use and Cravings", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cocaine-Related Disorders", "Substance-Related Disorders" ], "interventions": [ { "name": "quetiapine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Seattle Institute for Biomedical and Clinical Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 42, "start_date": "2003-10", "completion_date": "2006-01", "has_results": false, "last_update_posted_date": "2024-04-19", "last_synced_at": "2026-10-04T00:11:28.290Z", "location_count": 1, "location_summary": "Tacoma, Washington", "locations": [ { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00232336" } ] }